Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Centre hospitalier de l'Université de Montréal (CHUM)
With
Quebec Breast Cancer Foundation
Age
18–any
Sex
FEMALE
Healthy volunteers
Not accepted
You may be eligible if
Conditions for patient eligibility
Patients must be female.
Patients must be 18 years of age or older.
Patients with stage IIA, IIB, IIIA (T1-3 and N1-2) breast cancer. Clinical N0 accepted if biopsy proven node disease.
Patients that have biopsy proven positive axillary disease made by core needle biopsy or fine needle aspiration .
Patients that accept to undergo neoadjuvant chemotherapy; patients are eligible until the day of surgery.
Patients with bilateral breast cancer are eligible. Sentinel node biopsy is allowed on the contralateral breast if there is no disease in the axilla prior to chemotherapy.
Patients that understand, accept and have signed the approved consent form.
You may not be if
Patients with inflammatory breast cancer.
Patient with stage IIIB, IIIC or IV breast cancer (T4 and N3) Patients with clinical N3 disease are excluded.
Patients that have had previous axillary dissection or an axillary sentinel node biopsy; (patients that have had excisional biopsy or ipsilateral tumorectomy are eligible).
Patients that have had previous radiotherapy to the axillary nodes
Patients that have had mammary reduction
Patients that are medically unfit to receive chemotherapy, as evaluated by the treating physician.
If the injection of blue dye is planned, patients with hypersensitivity or allergy to isosulfan blue, Patent blue or methylene blue or radiocolloid dye are ineligible.
Patients who are pregnant or breast feeding .
Psychiatric or addictive disorders or other conditions that preclude the patient from meeting the study requirements.
Clareo Health | Sentinel Node Biopsy Following NeoAdjuvant Chemotherapy in Biopsy Proven Node Positive Breast Cancer
